RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., the leader in metabolomics-driven biomarker discovery, announced today the acquisition of intellectual property from Cogenics Icoria, Inc. (f/k/a/ Icoria, Inc.), a subsidiary of Clinical Data, Inc. The portfolio includes issued and pending patents related to metabolomics methods and data analysis as well as carcinogenicity and toxicity biomarkers. Metabolon now owns all of the metabolomics-related intellectual property formerly owned by Cogenics Icoria. Clinical Data acquired Cogenics Icoria in 2005.
